Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2020-10-23 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
独立董事关于第六届董事会第十次会议相关事项的独立意见
Regulatory Filings Classification · 95% confidence The document is an independent directors' opinion on the company's 2020 third quarter report. It references the third quarter report but does not contain the report itself or detailed financial data. The document is short (575 characters) and serves as an attestation or opinion rather than a full financial report. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than as an Interim/Quarterly Report (IR).
2020-10-23 Chinese
第六届监事会第十次会议决议的公告
Report Publication Announcement Classification · 95% confidence The document is an announcement of the supervisory board meeting resolution approving the company's 2020 third quarter report. It states that the supervisory board reviewed and approved the report, confirming its compliance and accuracy. However, the actual 2020 third quarter report is referenced as being available elsewhere (with links and announcement numbers provided). The document length is short (810 characters) and primarily serves to announce the approval and availability of the quarterly report, not the report itself. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement rather than the Interim/Quarterly Report itself.
2020-10-23 Chinese
第六届董事会第十次会议决议的公告
Regulatory Filings Classification · 95% confidence The document is an announcement of the resolutions from the sixth board of directors' tenth meeting of 嘉事堂药业股份有限公司. It specifically mentions the approval of the '2020 Third Quarter Report' and provides summary financial figures for the third quarter and first three quarters of 2020. The document also references where the full third quarter report can be found (on the company's designated disclosure website and media). The document length is short (1062 characters) and it primarily serves as a notice of the board meeting resolution approving the quarterly report rather than the full report itself. According to the 'Menu vs Meal' rule, this is an announcement related to an interim/quarterly report but not the report itself. Therefore, the document is best classified as a Regulatory Filing (RNS) because it is a formal announcement of the board meeting resolution and summary financial data, not the full quarterly report containing substantive financial statements and analysis.
2020-10-23 Chinese
独立董事关于第六届董事会第九次会议相关事项的独立意见
Audit Report / Information Classification · 95% confidence The document is an independent directors' opinion on the company's 2020 semi-annual report and related matters, including accounting policy changes, related party transactions, and external guarantees. It references the 2020 half-year report and provides an independent opinion on its accuracy and compliance with accounting standards. The document is relatively short (1136 characters) and does not contain the full financial statements or detailed financial data itself, but rather an opinion on the semi-annual report. This type of document is typically part of the audit or internal control disclosures related to interim reports but is not the interim report itself. Given the nature of the content focusing on audit opinions and compliance, the best fitting category is Audit Report / Information (AR). H1 2020
2020-08-25 Chinese
2020年半年度报告
Interim / Quarterly Report Classification · 99% confidence The document is titled '嘉事堂药业股份有限公司 2020 年半年度报告全文', which translates to 'Cachet Pharmaceutical Co., Ltd 2020 Semi-Annual Report Full Text'. It contains detailed financial data, including revenue, profit, cash flow, assets, liabilities, and business analysis for the period January 1, 2020 to June 30, 2020. The document includes sections such as company overview, financial indicators, business summary, management discussion and analysis, and financial statements. The length is about 15,000 characters, indicating a comprehensive report rather than a brief announcement. The presence of actual financial statements and substantive financial data confirms it is a financial report for a period shorter than a full fiscal year. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2020
2020-08-25 Chinese
关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a change in accounting policy related to the adoption of a new lease accounting standard. It details the reasons for the change, the impact on the company, and includes opinions from the board, independent directors, and the supervisory board. The document is relatively short (2095 characters) and does not contain financial statements or detailed financial data. It is an announcement of a policy change rather than a full financial report or audit report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-08-25 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.